Anthem Biosciences Ltd

NSE: ANTHEM · BSE: 544449 · Pharmaceuticals & Biotechnology · 37 announcements

Share price: ₹957.50
Market cap: ₹53,926 Cr
Revenue (annual): ₹2,124 Cr
Net profit (annual): ₹591.8 Cr
P/E (TTM): 87.8×Sector 43.8×
Promoter holding: 71.40%-0.02% QoQ
FII holding: 3.79%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 7 Financial Results 4 Results Update 3 Other Announcement 3 Business Update 2 Board Meeting Date 2 Annual Report 2 Annual General Meeting 2 Results Correction 1 Management Change 1 Legal & Regulatory 1 Employee Stock Options 1 Dividend 1 Credit Rating 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

32 announcements with these filters

19 May 2026 18:53 IST NSE

Financial ResultsAlfa Alert

Anthem Biosciences Q4 FY26 Results: Net Profit ₹189.8 Cr, Up 129.8% YoY

Anthem Biosciences Ltd reported revenue from operations of ₹610.9 Cr (+26.4% YoY) and net profit of ₹189.8 Cr (+129.8% YoY) for Q4 FY26.

Key figure: Net profit ₹189.8 Cr · +129.8% YoY

Open full results → Read the filing ↗

19 May 2026 18:51 IST NSE

Financial Results

Anthem Biosciences Financial Results

Anthem Biosciences Limited approved its audited annual financial results for fiscal year 2026. The Board also recommended a final dividend of ₹2.00 per share.

Open announcement → Read the filing ↗